✦ LIBER ✦
CASE 3 APPLICATION OF COST-EFFECTIVENESS ANALYSIS TO EVALUATE THE PROPOSED FORMULARY STATUS OF A NOVEL ANTIDIABETIC DRUG IN A U.S. COMMERCIAL HEALTH PLAN
✍ Scribed by J Watkins; M Minshall; SD Sullivan
- Book ID
- 118608700
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 65 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.